Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Adel, Astellas, Aston, Astrazeneca, Bioray, Biosyngen, Daiichi Sankyo, Dizal, Innocare, Oscotec, Takeda.